Abstract:Fungal infections remain a significant concern for human health. The emergence of microbial resistance, the improper use of antimicrobial drugs, and the need for fewer toxic antifungal treatments in immunocompromised patients have sparked substantial interest in antifungal research. Cyclic peptides, classified as antifungal peptides, have been in development as potential antifungal agents since 1948. In recent years, there has been growing attention from the scientific community to explore cyclic peptides as a promising strategy for combating antifungal infections caused by pathogenic fungi. The identification of antifungal cyclic peptides from various sources has been possible due to the widespread interest in peptide research in recent decades. It is increasingly important to evaluate narrow- to broad-spectrum antifungal activity and the mode of action of synthetic and natural cyclic peptides for both synthesized and extracted peptides. This short review aims to highlight some of the antifungal cyclic peptides isolated from bacteria, fungi, and plants. This brief review is not intended to present an exhaustive catalog of all known antifungal cyclic peptides but rather seeks to showcase selected cyclic peptides with antifungal properties that have been isolated from bacteria, fungi, plants, and synthetic sources. The addition of commercially available cyclic antifungal peptides serves to corroborate the notion that cyclic peptides can serve as a valuable source for the development of antifungal drugs. Additionally, this review discusses the potential future of utilizing combinations of antifungal peptides from different sources. The review underscores the need for the further exploration of the novel antifungal therapeutic applications of these abundant and diverse cyclic peptides.

Cyclic depsipeptides as potential cancer therapeutics

Cyclic Peptides in Pipeline: What Future for These Great Molecules?

Cyclic peptide therapeutics: past, present and future

Cyclic Peptides with Antifungal Properties Derived from Bacteria, Fungi, Plants, and Synthetic Sources

Exploring the Potential of Cyclic Peptidyl Antitumor Agents Derived from Natural Macrocyclic Peptide Phakellistatin 13

Development and Challenges of Cyclic Peptides for Immunomodulation

Cyclic peptides: a powerful instrument for advancing biomedical nanotechnologies and drug development

DFT-aided infrared and electronic circular dichroism spectroscopic study of cyclopeptide S-PK6 and the exploration of its antitumor potential by molecular docking

Cyclotides, a Novel Ultrastable Polypeptide Scaffold for Drug Discovery

Cyclodepsipeptides: Isolation, Bioactivities, Biosynthesis and Total Synthesis

Antiproliferative Cyclodepsipeptides from the Marine Actinomycete Streptomyces Sp. P11-23B Downregulating the Tumor Metabolic Enzymes of Glycolysis, Glutaminolysis, and Lipogenesis.

Exploration of Novel Macrocyclic Dipeptide N-benzyl Amides As Proteasome Inhibitors.

Cyclic Cell-Penetrating Peptides as Efficient Intracellular Drug Delivery Tools

Utilization of Macrocyclic Peptides to Target Protein-Protein Interactions in Cancer.

Cyclic peptide drugs approved in the last two decades (2001–2021)

A Broad Review of Plant-Derived Bioactive Peptides to combat Pathogenic Outbreaks - A Future Peptide based Therapeutic Approach

Marine bioactive peptides with anticancer potential, a narrative review

Novel Isoindolinone-Based Analogs of the Natural Cyclic Peptide Fenestin A: Synthesis and Antitumor Activity.

Applications of amphipathic and cationic cyclic cell-penetrating peptides: Significant therapeutic delivery tool

Structural analysis, spectroscopic characterization and molecular docking studies of the cyclic heptapeptide

CyclicPepedia: a knowledge base of natural and synthetic cyclic peptides